Now showing items 1-6 of 6

    • Association of Medical Students' Reports of Interactions with the Pharmaceutical and Medical Device Industries and Medical School Policies and Characteristics: A Cross-Sectional Study 

      Yeh, James S.; Austad, Kirsten E.; Franklin, Jessica M.; Chimonas, Susan; Campbell, Eric G.; Avorn, Jerry; Kesselheim, Aaron S. (Public Library of Science, 2014)
      Background: Professional societies use metrics to evaluate medical schools' policies regarding interactions of students and faculty with the pharmaceutical and medical device industries. We compared these metrics and ...
    • Comparative effectiveness of generic versus brand-name antiepileptic medications 

      Gagne, Joshua J; Kesselheim, Aaron Seth; Choudhry, Niteesh Kumar; Polinski, Jennifer Milan; Hutchins, David; Matlin, Olga S.; Brennan, Troyen Anthony; Avorn, Jerry Lewis; Shrank, William (Elsevier BV, 2015)
      OBJECTIVE: The objective of this study was to compare treatment persistence and rates of seizure-related events in patients who initiate antiepileptic drug (AED) therapy with a generic versus a brand-name product. METHODS: ...
    • Equity in the Receipt of Oseltamivir in the United States During the H1N1 Pandemic 

      Franklin, Jessica Myers; Choudhry, Niteesh Kumar; Uscher-Pines, Lori; Brill, Gregory; Matlin, Olga S.; Fischer, Michael Adam; Schneeweiss, Sebastian; Avorn, Jerry Lewis; Brennan, Troyen Anthony; Shrank, William (American Public Health Association, 2014)
      Objectives. We assessed the relationship between individual characteristics and receipt of oseltamivir (Tamiflu) in the United States during the H1N1 pandemic and other flu seasons. Methods. In a cohort of individuals ...
    • Medication Adherence and Healthcare Disparities: Impact of Statin Co-Payment Reduction 

      Lewey, Jennifer; Shrank, William; Avorn, Jerry Lewis; Liu, Jun; Choudhry, Niteesh Kumar (Managed Care & Healthcare Communications, 2015)
      Objectives: Minority patients have lower rates of cardiovascularmedication adherence, which may be amenable to co-payment reductions.Our objective was to evaluate the effect of race on adherencechanges following a statin ...
    • Patient, Physician, and Payment Predictors of Statin Adherence 

      Chan, David Chimin; Shrank, William H.; Cutler, David M.; Jan, Saira; Fischer, Michael Adam; Liu, Jun; Avorn, Jerry Lewis; Solomon, Daniel Hal; Brookhart, Alan; Choudhry, Niteesh K (American Public Health Association, 2010)
      BACKGROUND: Although many patient, physician, and payment predictors of adherence have been described, knowledge of their relative strength and overall ability to explain adherence is limited. OBJECTIVES: To measure the ...
    • Trends in Insulin Initiation and Treatment Intensification Among Patients with Type 2 Diabetes 

      Patrick, Amanda; Fischer, Michael Adam; Choudhry, Niteesh Kumar; Shrank, W; Seeger, John; Liu, Jun; Avorn, Jerry Lewis; Polinski, Jennifer Milan (Springer Science + Business Media, 2014)
      BACKGROUND: Many patients with type 2 diabetes eventually require insulin, yet little is known about the patterns and quality of pharmacologic care received following insulin initiation. Guidelines from the American Diabetes ...